Abstract
The COVID-19 pandemic goes along with increased mortality from acute respiratory disease. It has been suggested that vitamin D3 supplementation might help to reduce respiratory disease mortality. We assessed the prevalence of vitamin D insufficiency and deficiency, defined by 25-hydroxyvitamin D (25(OH)D) blood levels of 30–50 and 3 supplementation could be helpful to limit the burden of the COVID-19 pandemic, particularly among women.
All Related Versions
Funding Information
  • Bundesministerium für Forschung, Technologie und Raumfahrt (01ET0717, 01GY1320A)

This publication has 31 references indexed in Scilit: